Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Migraine Ice

This article was originally published in The Tan Sheet

Executive Summary

Mentholatum's "Cooling Headache Pads" reaching food, drug and mass outlets nationwide in May. The pads contain a "water-based gel with natural ingredients" and are shaped to fit the forehead, temples and back of the neck. Pads for the back of the neck and temple come four to a box, while forehead pads come five to a box; each retails for $9.99. Labeling claims the line provides "Instant soothing, cooling relief that lasts for hours" and is "Safe to use with medications." Consumers can receive a free brochure on migraine management tips and $1-off coupons for Migraine Ice by calling Mentholatum at 877-2-SOOTHE or visiting the Web site www.migraineice.com

You may also be interested in...



Mentholatum Aims To Ice FDA Warning Letter Concerns

The Mentholatum Co. is continuing to sell its Migraine Ice cooling headache pads during ongoing negotiations with FDA regarding the labeling claims for the OTC device. FDA cited unapproved headache and migraine relief claims in an April 18 warning letter to the firm.

Mentholatum Aims To Ice FDA Warning Letter Concerns

The Mentholatum Co. is continuing to sell its Migraine Ice cooling headache pads during ongoing negotiations with FDA regarding the labeling claims for the OTC device. FDA cited unapproved headache and migraine relief claims in an April 18 warning letter to the firm.

Mentholatum Aims To Ice FDA Warning Letter Concerns

The Mentholatum Co. is continuing to sell its Migraine Ice cooling headache pads during ongoing negotiations with FDA regarding the labeling claims for the OTC device. FDA cited unapproved headache and migraine relief claims in an April 18 warning letter to the firm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel